Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

Nuevo objetivo “universal” para el tratamiento antiviral

Con nuevos virus que representan una amenaza…

US hospitals lost $22.3B delaying elective surgeries, study estimates

As a result of the pandemic, a study shared by…

Health Care Paradox: Medicare Penalizes Dozens of Hospitals It Also Gives Five Stars

Health Care Paradox: Medicare Penalizes Dozens…

¿Nueva pandemia? La influenza H3N2 enciende las alarmas en Europa

La gripe H3N2, una variante de la influenza A,…

17-year-old makes color changing sutures that detect infection

Recently the PBS News Hour featured an episode…

Audio: Covid-19 and Contact Tracing

Eric Rubin is the Editor-in-Chief of the …

GLP-1 y salud ósea: ¿un nuevo riesgo en la mira? 

El péptido 1 similar al glucagón, mejor conocido…

56% de los brotes de sarampión se concentran en Jalisco 

El Informe Diario del Brote de Sarampión en…